Pharmabiz47m
Bayer to unveil new data from its phase III OASIS 3 long-term study of elinzanetant to treat vasomotor symptoms associated with menopause
Bayer to unveil new data from its phase III OASIS 3 long-term study of elinzanetant to treat vasomotor symptoms associated with menopause: Berlin Friday, September 6, 2024, 11:00 ...
Pharmabiz1h
Britain takes decisive action to ban 'zombie drug' xylazine and 21 other dangerous drugs
Britain takes decisive action to ban 'zombie drug' xylazine and 21 other dangerous drugs: United Kingdom Friday, September 6, 2024, 10:00 Hrs [IST] Legislation has been laid in Pa ...
Pharmabiz2h
Abbott starts TRANSCEND study to evaluate the use of its DBS system to manage severe depression
Abbott Park, Illinois Friday, September 6, 2024, 09:00 Hrs [IST] ...
Pharmabiz3h
KPRDO urges govt to look into the issue of strip cuttings of medicines & redesign drug packs
Nandita Vijayasimha, Bengaluru Friday, September 6, 2024, 08:00 Hrs [IST] ...
Pharmabiz3h
APTI to pass resolution demanding reservation of all jobs in drug manufacturing industry for pharmacy professionals
Peethaambaran Kunnathoor, Chennai Friday, September 6, 2024, 08:00 Hrs [IST] ...
Pharmabiz3h
DGFT amends export obligation period for imports of drugs from unregistered sources towards ease of doing business
Shardul Nautiyal, Mumbai Friday, September 6, 2024, 08:00 Hrs [IST] ...
Pharmabiz3h
Health ministry adds primary hyperoxaluria under NPRD to offer financial assistance
Health ministry adds primary hyperoxaluria under NPRD to offer financial assistance: Our Bureau, New Delhi Friday, September 6, 2024, 08:00 Hrs [IST] The Union ministry of health ...
Pharmabiz3h
PLI scheme for bulk drugs reports investment of Rs. 287 crore in July
PLI scheme for bulk drugs reports investment of Rs. 287 crore in July: Gireesh Babu, New Delhi Friday, September 6, 2024, 08:00 Hrs [IST] The production linked incentive (PLI) sch ...
Pharmabiz17h
Acepodia inks clinical collaboration with Pfizer to accelerate development of ACC-based cell therapies in autoimmune diseases
Acepodia inks clinical collaboration with Pfizer to accelerate development of ACC-based cell therapies in autoimmune diseases: Alameda, California Thursday, September 5, 2024, 18: ...
Pharmabiz19h
Bayer introduces new healthy-aging ecosystem for consumers
Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging ...
Pharmabiz22h
Roche to present positive phase II FENopta OLE study data of BTK inhibitor, fenebrutinib to treat relapsing MS at 40th Congress of ECTRIMS
Roche to present positive phase II FENopta OLE study data of BTK inhibitor, fenebrutinib to treat relapsing MS at 40th Congress of ECTRIMS: Basel Thursday, September 5, 2024, 13:0 ...
Pharmabiz18h
Hong Kong Baptist University gets China NMPA nod to begin trial with Chinese herbal formulation for ulcerative colitis
Hong Kong Baptist University gets China NMPA nod to begin trial with Chinese herbal formulation for ulcerative colitis: Hong Kong Thursday, September 5, 2024, 17:00 Hrs [IST] The ...